Table 9 Century II trial results (1 year follow-up)
From: Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
Stent name | Patient number | Cardiac death (%) | ST (%) | TLF (%) | MI-TV (%) | TLR |
|---|---|---|---|---|---|---|
Xience V | 550 | 1.3 | 1.3 | 7.8 | 2.2 | 3.9 |
Ultimaster | 551 | 2.2 | 0.4 | 5.3 | 1.3 | 2.2 |